| Clinical and geographical variation in prophylactic and therapeutic treatments for pre-eclampsia in the UK. | |
| | |
MedLine Citation:
|
PMID: 20175876 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To evaluate the clinical and geographical variation in the use of aspirin in women at high risk of pre-eclampsia, and in the use of antihypertensive drugs and magnesium sulphate in women with established pre-eclampsia. DESIGN: Analysis of vitamins in pre-eclampsia (VIP) trial database. SAMPLE: A total of 2399 women at increased risk of pre-eclampsia in 25 UK hospitals. METHODS: An analysis of a large prospectively validated database of high-risk women in the UK was undertaken to assess aspirin use across different risk groups and to evaluate the use of antihypertensives and magnesium sulphate in 370 women who developed pre-eclampsia. Logistic regression was employed to compare drug use between region and by recognised clinical indicators. MAIN OUTCOME MEASURES: Usage of aspirin, antihypertensive drugs and magnesium sulphate. RESULTS: Of the women with known risk factors at trial entry, 24% (569/2399) received low-dose aspirin. Aspirin usage varied widely between risk groups [from 5% (19/378) in women with multiple pregnancy to 94% (50/53) in women with antiphospholipid syndrome] and between geographical regions [from 8% (20/248) to 49% (95/193)]. Three hundred and seventy women developed pre-eclampsia, 52% (n = 193) of whom received new or additional antihypertensives after 20 weeks of gestation; 34% (77/224) with a maximum recorded systolic blood pressure of >OR=160 mmHg in the second half of pregnancy did not receive antihypertensive treatment; 17% (62/370) of women with pre-eclampsia received magnesium sulphate prophylactically. CONCLUSIONS: Prophylactic and treatment regimes for pre-eclampsia in the UK vary by region and risk group. |
| | |
Authors:
|
L C Chappell; P Seed; S Enye; A L Briley; L Poston; A H Shennan |
Related Documents
:
|
11483926 - Inhibition of cyclooxygenase but not nitric oxide synthase influences effects on the hu... 14672476 - Human chorionic gonadotropin and vascular endothelial growth factor in normal and compl... 2234646 - Poor participation of nulliparous women in a low dose aspirin study to prevent preeclam... 12623936 - Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. 20005516 - Lipoprotein-associated phospholipase a(2), inflammatory biomarkers, and risk of cardiov... 16567336 - Arresting developments: trends in female arrests for domestic violence and proposed exp... |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't Date: 2010-02-22 |
Journal Detail:
|
Title: BJOG : an international journal of obstetrics and gynaecology Volume: 117 ISSN: 1471-0528 ISO Abbreviation: BJOG Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-04-08 Completed Date: 2010-06-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100935741 Medline TA: BJOG Country: England |
Other Details:
|
Languages: eng Pagination: 695-700 Citation Subset: AIM; IM |
Affiliation:
|
Maternal and Fetal Research Unit, Division of Reproduction and Endocrinology, King's College London School of Biomedical and Health Sciences, London, UK. lucy.chappell@kcl.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anticonvulsants / therapeutic use* Antihypertensive Agents / therapeutic use* Aspirin / therapeutic use* Female Great Britain Humans Magnesium Sulfate / therapeutic use* Platelet Aggregation Inhibitors / therapeutic use* Pre-Eclampsia / drug therapy*, prevention & control Pregnancy Residence Characteristics Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Anticonvulsants; 0/Antihypertensive Agents; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; 7487-88-9/Magnesium Sulfate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Few fathers-to-be prefer caesarean section for the birth of their baby.
Next Document: FoxP1 promotes midbrain identity in embryonic stem cell-derived dopamine neurons by regulating Pitx3...